Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial
L. Klinge, V. Straub, U. Neudorf, J. Schaper, T. Bosbach, K. Görlinger, M. Wallot, S. Richards, T. VoitVolume:
15
Year:
2005
Language:
english
DOI:
10.1016/j.nmd.2004.10.009
File:
PDF, 378 KB
english, 2005